Endogenous retinoids in the pathogenesis of alopecia areata

Journal of Investigative Dermatology

Volumn 133, Issue 2, 2013, Pages 334-343

  Duncan, F Jason ^a   Silva, Kathleen A ^b   Johnson, Charles J ^a   King, Benjamin L ^b   Szatkiewicz, Jin P ^b   Kamdar, Sonya P ^b   Ong, David E ^c   Napoli, Joseph L ^d   Wang, Jinshan ^d   King Jr , Lloyd E ^c   Whiting, David A ^e   McElwee, Kevin J ^f   Sundberg, John P ^b,c   Everts, Helen B ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b JACKSON LABORATORY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BAYLOR HEALTH CARE SYSTEM   (United States)

^f UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; RANTES; RETINOIC ACID; RETINOID; RETINOL;

ALOPECIA AREATA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; HAIR FOLLICLE; HAIR GROWTH; HUMAN; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; SKIN BIOPSY; SYNTHESIS;

EID: 84872613943     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.344     Document Type: Article

References (92)

1. Afonina IS, Cullen SP, Martin SJ (2010) Cytotoxic and non-cytotoxic roles of the CTL/NK protease granzyme B. Immunol Rev 235:105-16
2. Anzano MA, Lamb AJ, Olson JA (1979) Growth, appetite, sequence of pathological signs and survival following the induction of rapid, synchronous vitamin A deficiency in the rat. J Nutr 109:1419-31
3. Arca E, Musabak U, Akar A et al. (2004) Interferon-gamma in alopecia areata. Eur J Dermatol 14:33-6
4. Arechalde A, Saurat JH (2000) Retinoids: unapproved uses or indications. Clin Dermatol 18:63-76
5. Asseman C, Mauze S, Leach MW et al. (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190:995-1004
6. Asseman C, Powrie F (1998) Interleukin 10 is a growth factor for a population of regulatory T cells. Gut 42:157-8
7. Balmer JE, Blomhoff R (2002) Gene expression regulation by retinoic acid. J Lipid Res 43:1773-808
8. Barahmani N, Lopez A, Babu D et al. (2009) Serum T helper 1 cytokine levels are greater in patients with alopecia areata regardless of severity of atopy. Clin Exp Dermatol 35:409-16
9. Boivin WA, Cooper DM, Hiebert PR et al. (2009) Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma. Lab Invest 89:1195-220
10. + dendritic cells. J Exp Med 204:3147-56
11. Cantorna MT, Nashold FE, Hayes CE (1994) In vitamin A deficiency multiple mechanisms establish a regulatory T-helper cell imbalance with excess Th1 and insufficent Th2 function. J Immunol 152:1515-22
12. Carroll JM, McElwee KJ, King LEJ et al. (2002) Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J Invest Dermatol 119:392-402
13. Cerwenka A, Bakker ABH, McClanahan T et al. (2000) Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12:721-7
14. + regulatory T cells via a TGF-beta-and retinoic acid-dependent mechanism. J Exp Med 204:1757-64
15. Cotsarelis G, Sun TT, Lavker RM (1990) Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 61:1329-37
16. Deeths MJ, Endrizzi BT, Irvin ML et al. (2006) Phenotypic analysis of T-cells in extensive alopecia areata scalp suggests partial tolerance. J Invest Dermatol 126:366-73
17. Duncan FJ, Martin JR, Wulff BC et al. (2009) Topical treatment with black raspberry extract reduces cutaneous uvb-induced carcinogenesis and inflammation. Cancer Prev Res 2:665-72
18. Duriancik DM, Lackey DE, Hoag KA (2010) Vitamin A as a regulator of antigen presenting cells. J Nutr 140:1395-9
19. Everts HB (2012) Endogenous retinoids in the hair follicle and sebaceous gland. Biochim Biophys Acta 1821:222-9
20. Everts HB, Berdanier CD (2002) Nutrient-gene interactions in mitochondrial function: vitamin A needs are increased in BHE/Cdb rats. IUBMB Life 53:289-94
21. Everts HB, Sundberg JP, King LE Jr. et al. (2007) Immunolocalization of enzymes, binding proteins, and receptors sufficient for retinoic acid synthesis and signaling during the hair cycle. J Invest Dermatol 127:1593-604
22. Fife BT, Bluestone JA (2008) Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 224:166-82
23. Flier J, Boorsma DM, van Beek PJ et al. (2001) Differential expression of CXCR3 targeting chemokines CXCL10, CXCL9, and CXCL11 in different types of skin inflammation. J Pathol 194:398-405
24. Flowers MT, Paton CM, O'Byrne SM et al. (2011) Metabolic changes in skin caused by Scd1 deficiency: a focus on retinol metabolism. PLoS One 6:e19734
25. Fontenot JD, Rasmussen JP, Gavin MA et al. (2005) A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6:1142-51
26. Freyschmidt-Paul P, McElwee KJ, Happle R et al. (2002) Interleukin-10-deficient mice are less susceptible to the induction of alopecia areata. J Invest Dermatol 119:980-2
27. Freyschmidt-Paul P, McElwee KJ, Hoffmann R et al. (2005) Reduced expression of interleukin-2 decreases the frequency of alopecia areata onset in C3H/HeJ mice. J Invest Dermatol 125:945-51
28. Freyschmidt-Paul P, McElwee KJ, Hoffmann R et al. (2006) Interferon-gamma-deficient mice are resistant to the development of alopecia areata. Br J Dermatol 155:515-21
29. Gilhar A, Kam Y, Assy B et al. (2005) Alopecia areata induced in C3H/HeJ mice by interferon-gamma: evidence for loss of immune privilege. J Invest Dermatol 124:288-9
30. Girard C, Dereure O, Blatiere V et al. (2006) Vitamin A deficiency phrynoderma associated with chronic giardiasis. Pediatr Dermatol 23:346-9
31. + T cells. J Immunol 160:3188-93
32. + regulatory T cells. Blood 115:1958-68
33. Harries MJ, Sun J, Paus R et al. (2010) Management of alopecia areata. BMJ 341:c3671
34. Hayashi H (1982) A review on the natural mediators of inflammatory leucotaxis. Acta Pathol Jpn 32(Suppl 2):271-84
35. Hoag KA, Nashold FE, Goverman J et al. (2002) Retinoic acid enhances the T helper 2 cell development that is essential for robust antibody responses through its action on antigen-presenting cells. J Nutr 132:3736-9
36. Housley WJ, O'Conor CA, Nichols F et al. (2009) PPAR gamma regulates retinoic acid-mediated DC induction of Tregs. J Leukoc Biol 86:293-301
37. Ito T, Ito N, Saatoff M et al. (2008) Maintenance of hair follicle immune privilege is linked to prevention of NK cell attack. J Invest Dermatol 128:1196-206
38. h2 development via retinoic acid receptors. Int Immunol 15:1017-25
39. Iwata M, Hirakiyama A, Eshima Y et al. (2004) Retinoic acid imprints gut-homing specificity on T cells. Immunity 21:527-38
40. Jinushi M, Takehara T, Tatsumi T et al. (2003) Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int J Cancer 104:354-61
41. John KK, Brockschmidt FF, Redler S et al. (2011) Genetic variants in CTLA4 are strongly associated with alopecia areata. J Invest Dermatol 131:1169-72
42. Kane MA, Folias AE, Napoli JL (2008a) HPLC/UV quantitation of retinal, retinol, and retinyl esters in serum and tissues. Anal Biochem 378:71-9
43. Kane MA, Folias AE, Wang C et al. (2008b) Quantitative profiling of endogenous retinoic acid in vivo and in vitro by tandem mass spectro-metry. Anal Chem 80:1702-8
44. Khabar KSA, Young HA (2007) Post-transcriptional control of the interferon system. Biochimie 89:761-9
45. King LE, McElwee KJ, Sundberg JP (2008) Alopecia Areata. In: Nickoloff BJ, Nestle FO (eds) Dermatologic Immunity, Curr Dir Autoimmun. Basel: Karger, 280-312
46. Kubeyinje EP, Cmathur M (1997) Topical tretinoin as an adjunctive therapy with intralesional triamcinolone acetonide for alopecia areata. Clinical experience in northern Saudi Arabia. Int J Dermatol 36:320
47. Kuwano Y, Fujimoto M, Watanabe R et al. (2007) Serum chemokine profiles in patients with alopecia areata. BrJ Dermatol 157:466-73
48. Langrish CL, Chen Y, Blumenschein WM et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233-40
49. Manicassamy S, Ravindran R, Deng JS et al. (2009) Toll-like receptor 2-dependent induction of vitamin A-metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat Med 15:401-9
50. Maynard CL, Hatton RD, Helms WS et al. (2009) Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells. J Exp Med 206:343-57
51. McElwee KJ, Boggess D, King LE Jr et al. (1998a) Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol 111:797-803
52. McElwee KJ, Boggess D, Miller J et al. (1999) Spontaneous alopecia areata-like hair loss in one congenic and seven inbred laboratory mouse strains. J Invest Dermatol Symp Proc 4:202-6
53. McElwee KJ, Boggess D, Olivry T et al. (1998b) Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology 66:90-107
54. + cells blockade disease onset in the C3H/HeJ mouse model. J Invest Dermatol 124:947-57
55. + cells. J Invest Dermatol 119:1426-33
56. McElwee KJ, Spiers EM, Oliver RF (1996) In vivo depletion of CD8+ T cells restores hair growth in the DEBR model for alopecia areata. BrJ Dermatol 135:211-7
57. McPhee CG, Duncan FJ, Silva KA et al. (2012) Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse. J Invest Dermatol 132:1736-8
58. Meyer KC, Klatte JE, Dinh HV et al. (2008) Evidence that the bulge region is a site of relative immune privilege in human hair follicles. BrJ Dermatol 159:1077-85
59. Mistry AR, O'Callaghan CA (2007) Regulation of ligands for the activating receptor NKG2D. Immunology 121:439-47
60. Much T (1976) Treatment of alopecia areata with vitamin A acid. Z Hautkr 51:993-8
61. Mucida D, Park Y, Kim G et al. (2007) Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 317:256-60
62. Nakae S, Saijo S, Horai R et al. (2003) IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci USA 100:5986-90
63. Nakamura M, Jo J, Tabata Y et al. (2008) Controlled delivery of T-box21 small interfering RNA ameliorates autoimmune alopecia (Alopecia Areata) in a C3H/HeJ mouse model. Am J Pathol 172:650-8
64. O'Garra A, Barrat FJ, Castro AG et al. (2008) Strategies for use of IL-10 or its antagonists in human disease. Immunol Rev223:114-31
65. Park SY, Murphy SP, Martin CL et al. (2008) Nutrient intake from multivitamin/mineral supplements is similar among users from five ethnic groups: The Multiethnic Cohort Study. J Am Diet Assoc 108:529-33
66. Pelidou SH, Zou LP, Deretzi G et al. (2000) Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role. Exp Neurol 163:165-72
67. Petukhova L, Duvic M, Hordinsky M et al. (2010) Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature 466:113-7
68. Poggi A, Catellani S, Garuti A et al. (2009) Effective in vivo induction of NKG2D ligands in acute myeloid leukaemias by all-trans-retinoic acid or sodium valproate. Leukemia 23:641-8
69. Rathanaswami P, Hachicha M, Sadick M et al. (1993) Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines. J Biol Chem 268:5834-9
70. Ries G, Hess R (1999) Retinol: Safety considerations for its use in cosmetic products. J Toxicol Cutaneous Ocul Toxicol 18:169-85
71. Ruzicka T, Sommerburg C, Goerz G et al. (1992) Treatment of cutaneous lupus-erythematosus with acitretin and hydroxychloroquine. BrJ Dermatol 127:513-8
72. Safavi KH, Muller SA, Suman VJ et al. (1995) Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 70:628-33
73. Sato-Kawamura M, Aiba S, Tagami H (2003) Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Arch Dermatol Res 294:536-43
74. Schambach F, Schupp M, Lazar MA et al. (2007) Activation of retinoic acid receptor-alpha favours regulatory T cell induction at the expense of IL-17-secreting T helper cell differentiation. Eur J Immunol 37:2396-9
75. Shih MYS, Kane MA, Zhou P et al. (2009) Retinol esterification by DGAT1 is essential for retinoid homeostasis in murine skin. J Biol Chem 284:4292-9
76. Shimokawa Y, Miura K, Hifumi M et al. (1983) Lymphocyte chemotaxis in inflammation. VI. Lyt phenotype analysis of effector cells responsible for producing murine lymphocyte chemotactic factor. Immunology 49:95-102
77. Siebenhaar F, Sharov AA, Peters EM et al. (2007) Substance P as an immunomodulatory neuropeptide in a mouse model for autoimmune hair loss (alopecia areata). J Invest Dermatol 127:1489-97
78. Smith SM, Levy NS, Hayes CE (1987) Impaired immunity in vitamin A deficient ice. J Nutr 117:857-65
79. Sojka DK, Huang YH, Fowell DJ (2008) Mechanisms of regulatory T-cell suppression-a diverse arsenal for a moving target. Immunology 124:13-22
80. Stephensen CB, Jiang XW, Freytag T (2004) Vitamin A deficiency increases the in vivo development of IL-10-positive Th2 cells and decreases development of Th1 cells in mice. J Nutr 134:2660-6
81. Stockinger B, Veldhoen M, Martin B (2007) Th17 T cells: linking innate and adaptive immunity. Sem Immunol 19:353-61
82. Subramanya RD, Coda AB, Sinha AA (2010) Transcriptional profiling in alopecia areata defines immune and cell cycle control related genes within disease-specific signatures. Genomics 96:146-53
83. Sundberg JP, Cordy WR, King LE Jr (1994) Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 102:847-56
84. Sundberg JP, McElwee KJ, Carroll JM et al. (2011) Hypothesis testing: CTLA4 co-stimulatory pathways critical in the pathogenesis of human and mouse alopecia areata. J Invest Dermatol 131:2323-4
85. Sundberg JP, Oliver RF, McElwee KJ et al. (1995) Alopecia areata in humans and other mammalian species. J Invest Dermatol 104:32S-3S
86. Sundberg JP, Silva KA, Li RH et al. (2004) Adult-onset alopecia areata is a complex polygenic trait in the C3H/HeJ mouse model. J Invest Dermatol 123:294-7
87. Talpur R, Vu J, Bassett R et al. (2009) Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata. J Am Acad Dermatol 61:592-8
88. Tang L, Cao L, Sundberg JP et al. (2004) Restoration of hair growth in mice with an alopecia areata-like disease using topical anthralin. Exp Dermatol 13:5-10
89. Tosti A, Duque-Estrada B (2009) Treatment strategies for alopecia. Expert Opin Pharmacother 10:1017-26
90. Wolbach SB, Howe PR (1925) Tissue changes following deprivation of fat-soluble A vitamin. J Exp Med 42:753-77
91. + regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression. J Immunol 181:2277-84
92. + regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol 118:983-92